Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Carl Quinion"'
Publikováno v:
Journal of Pediatric Orthopaedics. 41:e337-e341
Background Nearly 1 in 5 American children are obese. The primary purpose of this study is to evaluate the relationship between childhood obesity and perioperative complications, patient-reported outcomes (PRO), and functional recovery after closed r
Autor:
Stanley I. Martin, Robert A. Baiocchi, Carl Quinion, Mark E. Lustberg, Susan Geyer, Ronald P. Pelletier, Pierluigi Porcu, Michael A. Caligiuri
Publikováno v:
Transplantation. 99:1220-1225
Posttransplant lymphoproliferative disorder (PTLD) is an infrequent but serious complication of solid organ transplantation. Early detection and initiation of therapy may improve outcomes. The purpose of this study was to identify human leukocyte ant
Publikováno v:
Clinical Pharmacology & Therapeutics. 97:469-477
The B-cell receptor pathway (BCR) is aberrantly activated in select B-cell malignancies. This knowledge has allowed for the development of inhibitors of different crucial steps of this pathway. Bruton's tyrosine kinase (BTK) is a key component of BCR
Autor:
Jonathon B. Cohen, Timothy S. Fenske, Zeina Al-Mansour, Jeremy S. Abramson, Arun K Singavi, Steven I. Park, Gerard Lozanski, Stephanie Matthews, Girish Venkataraman, Alejandro A. Gru, Arletta Lozanski, Lapo Alinari, Carl Quinion, Peter Martin, Jacqueline N. Poston, Friederike Kreisel, Hana Iris Lim, Ying Huang, Eunhye Oak, Kristie A. Blum, Andrew M. Evens
De novo CD5+ diffuse large B-cell lymphomas (DLBCL) are a distinct subgroup of DLBCL with poor prognosis. However the role of rituximab-containing therapy and salvage stem cell transplantation in this patients' population remain to be defined. We ret
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee2d40a79bdc6e45e638ab8463d64118
Autor:
Carl Quinion, Claudio Agostinelli, Kiran V. Mahasenan, Saïd Sif, Chenglong Li, John C. Byrd, Vrajesh Karkhanis, Robert A. Baiocchi, Lapo Alinari, Tasneem Motiwala, Satavisha Roy, Olivier Elemento, Samson T. Jacob, Emily Smith, Alessandra De Leo, Rosa Lapalombella, Selina Chen-Kiang, Sarmila Majumder, Lisa Kim, John T. Patton, Stefano Pileri, Yun Wu, Fengting Yan, Bo Yu, Porsha Smith, James E. Bradner, Leona W. Ayers, Jihyun Chung
Publikováno v:
Blood. 125(16)
Epigenetic events that are essential drivers of lymphocyte transformation remain incompletely characterized. We used models of Epstein-Barr virus (EBV)–induced B-cell transformation to document the relevance of protein arginine methyltransferase 5
Autor:
Carl Quinion, Emilia Mahoney, Lapo Alinari, Lenguyen Huynh, Rajeswaran Mani, Christian T. Earl, William H. Towns, Robert A. Baiocchi, Mette Prætorius-Ibba, Kristie A. Blum, David M. Goldenberg, Ching-Shih Chen, Yicheng Mao, John T. Patton, Natarajan Muthusamy, Bo Yu, Xiaoli Zhang, John C. Byrd
Mantle cell lymphoma (MCL) is an aggressive B-cell malignancy with a short median survival despite multimodal therapy. FTY720, an immunosuppressive drug approved for the treatment of multiple sclerosis, promotes MCL cell death concurrent with down-mo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62a1c88c81c88987a9f5fb3dcf9b6678
https://europepmc.org/articles/PMC3568700/
https://europepmc.org/articles/PMC3568700/
Autor:
Fengting Yan, Mette Prætorius-Ibba, Lapo Alinari, Carl Quinion, Mark E. Lustberg, Rosa Lapalombella, Xiaoli Zhang, Bo Yu, David M. Goldenberg, Owen A. O'Connor, Natarajan Muthusamy, John C. Byrd, Beth Christian, Erin Hertlein, Robert A. Baiocchi, Kristie A. Blum, Jungook D. Shin, Gerard Lozanski
Publikováno v:
Blood. 117(17)
Mantle cell lymphoma (MCL) is an aggressive B-cell malignancy with a median survival of 3 years despite chemoimmunotherapy. Rituximab, a chimeric anti–CD20 monoclonal antibody (mAb), has shown only modest activity as single agent in MCL. The humani
Autor:
Beth Christian, Carl Quinion, Robert A. Baiocchi, Alejandro A. Gru, Steven M. Devine, Lapo Alinari, Kristie A. Blum, Ying Huang, Kami J. Maddocks, Jeffrey A. Jones
Publikováno v:
Blood. 124:1700-1700
Background. CD5+ diffuse large B-cell lymphomas (DLBCLs) are an uncommon subgroup of DLBCLs representing 5-10% of de novo DLBCLs. Compared with CD5- DLBCLs, de novo CD5+ DLBCLs are associated with a more aggressive clinical course with higher interna
Autor:
Christian T. Earl, Craig C. Hofmeister, Kristina Humphries, Steven M. Devine, Pierluigi Porcu, Leslie A. Andritsos, Carl Quinion, Kristie A. Blum, Joseph Zitesman, Sam Penza, Gerard Lozanski, Carli N Greenfield, Megan Sell, Mindy A Bowers, Mark E. Lustberg, Robert A. Baiocchi
Publikováno v:
Blood. 120:2004-2004
2004 [][1] Introduction: Autologous hematopoietic stem cell transplantation (HSCT) cures fewer than half of patients with aggressive non-Hodgkin's lymphoma (NHL). Vorinostat (SAHA, Zolinza) has shown activity in relapsed lymphoma and there is preclin
Autor:
Erin Hertlein, Lynda Villagomez, Bo Yu, Tasneem Motiwala, Sarmila Majumder, Porsha Smith, John C. Byrd, Christian T. Earl, John T. Patton, Fengting Yan, Carl Quinion, Mark E. Lustberg, Saïd Sif, Chenglong Li, Robert A. Baiocchi, Leona W. Ayers, Samson T. Jacob, Lapo Alinari
Publikováno v:
Blood. 120:2378-2378
Abstract 2378 Epstein-Barr virus (EBV) is a ubiquitous, gamma herpes virus that infects human epithelial cells and B lymphocytes. Over 90% of adults worldwide are infected with EBV and, collectively, this virus is associated with a broad spectrum of